U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07830901) titled 'Prevalence and Prognosis of Drug-Induced Liver Injury' on Sept. 15.
Brief Summary: Drug-induced liver injury (DILI) is an important cause of acute liver damage that occurs when prescription medications, over-the-counter drugs, herbal products, or dietary supplements harm the liver. DILI can range from mild abnormalities in liver enzymes that cause no symptoms to severe conditions such as acute liver failure, the need for an urgent liver transplant, or death. Diagnosing DILI is often challenging because it shares symptoms with many other liver diseases, and there are currently no single specific blood tests to confirm it.
There is ...